Clinical trial
Use of Rosuvastatin to Achieve Lipid Targets in African American Subjects With Cerebrovascular Disease
NCT01975194 is registered in ClinicalTrials.gov with Wayne State University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Use of Rosuvastatin to Achieve Lipid Targets in African American Subjects With Cerebrovascular Disease
- Lead sponsor
- Wayne State University
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- January 31, 2012
- Completion date
- August 31, 2013
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
stroke, transient ischemic attack